Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has shared an announcement.
BONESUPPORT HOLDING AB announced it will release its Q2 2025 interim report on July 15, followed by a conference call and webcast hosted by the CEO and CFO. This event will provide insights into the company’s performance and allow stakeholders to engage directly with the management, potentially impacting investor confidence and market positioning.
More about BONESUPPORT HOLDING AB
BONESUPPORT HOLDING AB is a leading company in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel into the patient’s own bone and have the capability of eluting drugs. The company is based in Lund, Sweden, and focuses on demonstrating the clinical and health economic benefits of its products through several clinical studies.
Average Trading Volume: 203,956
Current Market Cap: SEK19.05B
See more data about BONEX stock on TipRanks’ Stock Analysis page.